Display options
Cite
Khan UT, Kelly M, Dodd J, et al. Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study. J Clin Pathol. 2020;74(12):816-818doi: 10.1136/jclinpath-2020-207121.
Khan, U. T., Kelly, M., Dodd, J., Fergiani, S., Hammer, B., Smith, J., Arumainathan, A., Atherton, M., Carter, A., Racu-Amoasii, I., Kalakonda, N., Pettitt, A., & Menon, G. (2021). Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study. Journal of clinical pathology, 74(12), 816-818. https://doi.org/10.1136/jclinpath-2020-207121
Khan, Umair Tahir, et al. "Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study." Journal of clinical pathology vol. 74,12 (2021): 816-818. doi: https://doi.org/10.1136/jclinpath-2020-207121
Khan UT, Kelly M, Dodd J, Fergiani S, Hammer B, Smith J, Arumainathan A, Atherton M, Carter A, Racu-Amoasii I, Kalakonda N, Pettitt A, Menon G. Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study. J Clin Pathol. 2021 Dec;74(12):816-818. doi: 10.1136/jclinpath-2020-207121. Epub 2020 Dec 30. PMID: 33380460; PMCID: PMC8606458.
Copy Download .nbib Format: NLM
Share it on

J Clin Pathol. 2021 Dec;74(12):816-818. doi: 10.1136/jclinpath-2020-207121. Epub 2020 Dec 30.

Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study.

Journal of clinical pathology

Umair Tahir Khan, Michael Kelly, James Dodd, Sammy Fergiani, Barbara Hammer, Jeffrey Smith, Arvind Arumainathan, Mark Atherton, Anthony Carter, Igor Racu-Amoasii, Nagesh Kalakonda, Andrew Pettitt, Geetha Menon

Affiliations

  1. Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK [email protected].
  2. Department of Haematology, Royal Liverpool & Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  3. Department of Haemato-oncology, Clatterbridge Cancer Centre, Liverpool, UK.
  4. Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK.
  5. Department of Haematology, Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK.
  6. Department Haematology, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK.
  7. Department of Molecular Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
  8. Haemato-oncology Diagnostic Service, Liverpool Clinical Laboratories, Merseyside and Cheshire Cancer Network, Liverpool, UK.
  9. Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

PMID: 33380460 PMCID: PMC8606458 DOI: 10.1136/jclinpath-2020-207121

[No abstract available.]

Keywords: hematologic diseases; immunohistochemistry; lymphoma; proto-oncogene proteins c-myc

Conflict of interest statement

Competing interests: UTK is an MRC Clinical Training Fellow based at the University of Liverpool supported by the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology

References

  1. Histopathology. 2008 Aug;53(2):205-17 - PubMed
  2. Blood. 2013 May 16;121(20):4021-31; quiz 4250 - PubMed
  3. Blood. 2013 Mar 21;121(12):2253-63 - PubMed
  4. J Clin Oncol. 2012 Oct 1;30(28):3460-7 - PubMed
  5. J Clin Oncol. 2012 Oct 1;30(28):3452-9 - PubMed
  6. Clin Cancer Res. 2003 Jun;9(6):2133-9 - PubMed
  7. Leukemia. 2008 Dec;22(12):2226-9 - PubMed
  8. Br J Haematol. 2014 May;165(3):382-91 - PubMed

Publication Types

Grant support